COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drugs in silico
Last updated: 2023 Dec 18
Total hit(s): 1126
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38086763
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
J Enzyme Inhib Med Chem
2024 Dec
8.6
1
2
38713760
Correction to "Exploration of SARS-CoV-2 3CL(pro) Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay".
J Chem Inf Model
2024 May 7
4.04
1
3
38759218
Molecular docking based comparative study of antiviral compounds on SARS-CoV-2 spike protein.
Nat Prod Res
2024 May 17
3.9
1
4
38694063
Role of ribosomal pathways and comorbidity in COVID-19: Insight from SARS-CoV-2 proteins and host proteins interaction network analysis.
Heliyon
2024 May 15
1.65
1
5
38734638
Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
BMC Chem
2024 May 11
1
6
38732174
Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking.
Int J Mol Sci
2024 May 1
4.21
1
7
38550333
Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis.
Saudi Pharm J
2024 May
5.6
1
8
38592189
Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
J Biomol Struct Dyn
2024 Apr 9
3.22
1
9
38576396
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of omicron (B1.1.529) pseudovirus.
Virulence
2024 Apr 5
4.81
1
10
38582181
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis.
Radiother Oncol
2024 Apr 4
4.92
1
11
38728643
Drug repurposing: identification of SARS-CoV-2 potential inhibitors by virtual screening and pharmacokinetics strategies.
J Infect Dev Ctries
2024 Apr 30
1.26
1
12
38653779
Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study.
Sci Rep
2024 Apr 23
4.12
1
13
38655479
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation.
RSC Adv
2024 Apr 22
1
14
38675980
The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
Viruses
2024 Apr 20
3.76
1
15
38632526
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis.
Mol Med
2024 Apr 17
6.9
1
16
38616188
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro.
Sci Rep
2024 Apr 14
4.12
1
17
38423371
Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives.
Bioorg Med Chem Lett
2024 Apr 1
4.9
1
18
38508555
Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach.
Int J Biol Macromol
2024 Apr
4.94
1
19
38460087
In Silico Prediction of Functional SNPs Interrupting Antioxidant Defense Genes in Relation to COVID-19 Progression.
Biochem Genet
2024 Mar 9
1
20
38456332
Identification of Potential inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
ChemMedChem
2024 Mar 8
5.5
1
21
38443855
Identification of biomarkers and pathways for the SARS-CoV-2 infections in obstructive sleep apnea patients based on machine learning and proteomic analysis.
BMC Pulm Med
2024 Mar 5
2.21
1
22
38553521
A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response.
Sci Rep
2024 Mar 29
4.12
1
23
38535992
Native Mass Spectrometry Dissects the Structural Dynamics of an Allosteric Heterodimer of SARS-CoV-2 Nonstructural Proteins.
J Am Soc Mass Spectrom
2024 Mar 27
1
24
36415456
In-silico docking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2.
bioRxiv
2024 Mar 27
- n/a -
1
25
38520147
Discovery of small molecule entry inhibitors targeting the linoleic acid binding pocket of SARS-CoV-2 spike protein.
J Biomol Struct Dyn
2024 Mar 23
3.22
1